Patient Valuation of Primary Care-Based Treatment Options for Substance Use & Mental Health Disorders

Below:  Unadjusted self-reported willingness to enter treatment, by treatment type and price

Most individuals with substance use and mental health disorders do not receive treatment. If treatment options were more attractive, treatment rates might increase. Although the advantages of novel approaches, including primary care-based treatment and collaborative care in a primary care setting, have been documented, less is known about consumers’ valuation of these options. Contingent valuation methods were used to assess monetary valuation of these treatment types relative to usual care in specialty treatment using a national randomized experiment. Participants valued a primary care-based treatment visit over usual care by $9.00 and a collaborative care visit over usual care by $5.85.

Read more at:  http://ht.ly/QL716 HT @PennMedicine